"Ignoring the entire Quality category may be a risky strategy in 2020 and beyond," warns Robert A. Dowling, MD.
Robert A. Dowling, MD
"The mean and median MIPS final composite scores among urologists in 2017 were 79.3 and 91.2, respectively; this was slightly higher than all specialties combined," writes Robert A. Dowling, MD.
"On Nov. 1, 2019, CMS published a final rule making important changes to the 2020 Quality Payment Program (Merit-based incentive Payment System [MIPS] and alternative payment models). Among the most significant are changes to the MIPS Cost Category: changes in the way patients are attributed to physicians, changes in the way the cost measures are calculated, and the addition of new episode-based cost measures," writes Robert A. Dowling, MD.
"Automated urinalysis codes declined 19%, while the manual urinalysis codes without and with microscopy dropped 0.6% and 7.6% respectively over the 3-year period," writes Robert A. Dowling, MD.
Written policies should address scheduling guidelines and appointment cancellations, advises Robert A. Dowling, MD.
"Patient access to health information—whether it resides in a medical record, a lab company’s system, or an insurance company records—is a right firmly protected by federal laws and regulations," writes Robert A. Dowling, MD.
The average industry payment to a urologist saw a decline in 2018 compared with the previous year.
Robert A. Dowling, MD, discusses how the National Practitioner Data Bank can inform urologists about the prevalence and type of medical malpractice payments and adverse actions against health care providers in the U.S.
In this article, Robert A. Dowling, MD, discusses Part D drug spending that may be of interest to the practicing urologist: those drugs prescribed, and in some cases, dispensed in the urology practice.
In this article, Robert A. Dowling, MD, takes a look at Part B drug spending that may be of interest to the practicing urologist.